Belvin Gong
Overview
Explore the profile of Belvin Gong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
165
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Micheva K, Gong B, Collman F, Weinberg R, Smith S, Trimmer J, et al.
eNeuro
. 2023 Nov;
10(12).
PMID: 37945352
Antibody (Ab)-based imaging techniques rely on reagents whose performance may be application specific. Because commercial antibodies are validated for only a few purposes, users interested in other applications may have...
2.
Mitchell K, Gong B, Hunter S, Burkart-Waco D, Gavira-ONeill C, Templeton K, et al.
Sci Rep
. 2023 Sep;
13(1):16200.
PMID: 37758930
The Neuroscience Monoclonal Antibody Sequencing Initiative (NeuroMabSeq) is a concerted effort to determine and make publicly available hybridoma-derived sequences of monoclonal antibodies (mAbs) valuable to neuroscience research. Over 30 years...
3.
Mitchell K, Gong B, Hunter S, Burkart-Waco D, Gavira-ONeill C, Templeton K, et al.
bioRxiv
. 2023 Jul;
PMID: 37425915
The Neuroscience Monoclonal Antibody Sequencing Initiative (NeuroMabSeq) is a concerted effort to determine and make publicly available hybridoma-derived sequences of monoclonal antibodies (mAbs) valuable to neuroscience research. Over 30 years...
4.
Micheva K, Gong B, Collman F, Weinberg R, Smith S, Trimmer J, et al.
bioRxiv
. 2023 Jul;
PMID: 37425759
Antibody-based imaging techniques rely on reagents whose performance may be application-specific. Because commercial antibodies are validated for only a few purposes, users interested in other applications may have to perform...
5.
Dong J, Lee Y, Kirmiz M, Palacio S, Dumitras C, Moreno C, et al.
Elife
. 2019 Oct;
8.
PMID: 31566565
Nanobodies (nAbs) are small, minimal antibodies that have distinct attributes that make them uniquely suited for certain biomedical research, diagnostic and therapeutic applications. Prominent uses include as intracellular antibodies or...
6.
Andrews N, Boeckman J, Manning C, Nguyen J, Bechtold H, Dumitras C, et al.
Elife
. 2019 Jan;
8.
PMID: 30667360
Generating recombinant monoclonal antibodies (R-mAbs) from mAb-producing hybridomas offers numerous advantages that increase the effectiveness, reproducibility, and transparent reporting of research. We report here the generation of a novel resource...
7.
Simhal A, Gong B, Trimmer J, Weinberg R, Smith S, Sapiro G, et al.
Front Neuroanat
. 2018 Aug;
12:51.
PMID: 30065633
Application-specific validation of antibodies is a critical prerequisite for their successful use. Here we introduce an automated framework for characterization and screening of antibodies against synaptic molecules for high-resolution immunofluorescence...
8.
Gong B, Murray K, Trimmer J
N Biotechnol
. 2015 Dec;
33(5 Pt A):551-64.
PMID: 26644354
High-quality antibodies (Abs) are critical to neuroscience research, as they remain the primary affinity proteomics reagent used to label and capture endogenously expressed protein targets in the nervous system. As...
9.
Gong B, Kielar C, Morton A
PLoS One
. 2012 Aug;
7(7):e41450.
PMID: 22848498
Abnormal insoluble ubiqitinated protein aggregates are found in the brains of Huntington's disease (HD) patients and in mice transgenic for the HTT mutation. Here, we describe the earliest stages of...
10.
Edwardson J, Wang C, Gong B, Wyttenbach A, Bai J, Jackson M, et al.
J Biol Chem
. 2003 Jun;
278(33):30849-53.
PMID: 12807877
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by an expanded CAG repeat in the HD gene. We reported recently that complexin II, a protein involved in neurotransmitter...